The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), Eli Lilly and Co.

Corporate borrowers shrugged off fears over inflation and concerns over tariffs to print tight trades and pay for ...

The only other drug currently in its pipeline is RVT-104, a combination of glycopyrrolate and high dose rivastigmine, Novartis' off-patent Alzheimer's drug Exelon.

OTC Markets Group Inc. , operator of regulated markets for trading 12,000 U.S. and international securities, today announced Thiogenesis Therapeutics Corp. , a clinical-stage biotech company, has ...

Exelon Corp (NASDAQ:EXC) achieved top quartile reliability performance across all four of its utilities, with three ranking in the top five among peers. The company reported GAAP earnings of $2.45 ...

CHICAGO (AP) — CHICAGO (AP) — Exelon Corp. (EXC) on Wednesday reported fourth-quarter earnings of $647 million. The results exceeded Wall Street expectations. The average estimate of five analysts ...

Exelon Corporation EXC is scheduled to release fourth-quarter 2024 results on Feb. 12, before market open. The company delivered an earnings surprise of 5.97% in the last reported quarter. Exelon ...

CHICAGO (AP) — CHICAGO (AP) — Exelon Corp. (EXC) on Wednesday reported fourth-quarter earnings of $647 million. On a per-share basis, the Chicago-based company said it had profit of 64 cents.

(Reuters) -Major U.S. electric utility Exelon increased its four-year capital investment plan by 10% to $38 billion, with the bulk of the spending aimed at bolstering and building new transmission ...

Hello, and welcome to Exelon's Fourth Quarter Earnings Call. My name is Michelle, and I will be your event specialist today. [Operator Instructions] Please note that today's webcast is being recorded.

As 2023 comes to a close, we are reminded of John Bogle, the founder of The Vanguard Group, who was credited with popularizing the index fund. A man of many quotes and the author of a number of books, ...